RE-BVS – Piemonte Repository

Sfoglia per AUTORE
RAJE N
Collezione AOU Città della Salute di Torino

Items : 6

International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma. in The Lancet. Oncology / Lancet Oncol. 2024 May;25(5):e205-e216. doi: 10.1016/S1470-2045(24)00043-3.

2024
AOU Città della Salute di Torino

Rodriguez-Otero P; Usmani S; Cohen AD; van de Donk NWCJ; Leleu X; Gállego Pérez-Larraya J; Manier S; Nooka AK; Mateos MV; Einsele H; Minnema M; Cavo M; Derman BA; Puig N; Gay F; Ho PJ; Chng WJ; Kastritis E; Gahrton G; Weisel K; Nagarajan C; Schjesvold F; Mikhael J; Costa L; Raje NS; Zamagni E; Hájek R; Weinhold N; Yong K; et alii...

Immune Reconstitution and Vaccinations in Multiple Myeloma: A Report From the 19th International Myeloma Society Annual Workshop. in Clinical lymphoma, myeloma & leukemia / Clin Lymphoma Myeloma Leuk. 2023 Jun;23(6):413-419. doi: 10.1016/j.clml.2023.03.009. Epub 2023 Mar 2

2023
AOU Città della Salute di Torino

Dhodapkar MV; Avigan DE; Ludwig H; Jagannath S; Parekh S; D'Agostino M; van de Donk NWCJ; Neri P; Terpos E; Raje NS;

Monitoring, prophylaxis, and treatment of infections in patients with MM receiving bispecific antibody therapy: consensus recommendations from an expert panel. in Blood cancer journal / Blood Cancer J. 2023 Aug 1;13(1):116. doi: 10.1038/s41408-023-00879-7.

2023
AOU Città della Salute di Torino

Raje N; Anderson K; Einsele H; Efebera Y; Gay F; Hammond SP; Lesokhin AM; Lonial S; Ludwig H; Moreau P; Patel K; Ramasamy K; Mateos MV;

Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. in The Lancet. Oncology / Lancet Oncol. 2021 Mar;22(3):e105-e118. doi: 10.1016/S1470-2045(20)30756-7.

2021
AOU Città della Salute di Torino

Moreau P; Kumar SK; San Miguel J; Davies F; Zamagni E; Bahlis N; Ludwig H; Mikhael J; Terpos E; Schjesvold F; Martin T; Yong K; Durie BGM; Facon T; Jurczyszyn A; Sidana S; Raje N; van de Donk N; Lonial S; Cavo M; Kristinsson SY; Lentzsch S; Hajek R; Anderson KC; João C; Einsele H; Sonneveld P; Engelhardt M; Fonseca R; et alii...

Anti-BCMA CAR T-cell therapy in multiple myeloma: can we do better? in Leukemia / Leukemia. 2020 Jan;34(1):21-34. doi: 10.1038/s41375-019-0669-4. Epub 2019 Nov 28.

2020
AOU Città della Salute di Torino

Raje N; D'Agostino M;

Phase 2 study of tabalumab, a human anti-B-cell activating factor antibody, with bortezomib and dexamethasone in patients with previously treated multiple myeloma. in British journal of haematology / Br J Haematol. 2017 Mar;176(5):783-795. doi: 10.1111/bjh.14483. Epub 2016 Dec 22.

2017
AOU Città della Salute di Torino

Kaiser CJ; Conti I; Tai DF; Wooldridge JE; Kuliczkowski K; Beksac M; Huang SY; Oriol A; Holstein SA; Grz??ko N; Benboubker L; Terpos E; Raje NS; Moreau P; Nguyen TS; Cronier DM; Palumbo A;